Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

Yoichiro Hirakawa; Hisatomi Arima; Sophia Zoungas; Toshiharu Ninomiya; Mark Cooper; Pavel Hamet; Giuseppe Mancia; Neil Poulter; Stephen Harrap; Mark Woodward; John Chalmers

Journal article

Impact of Visit-to-Visit Glycemic Variability on the Risks of Macrovascular and Microvascular Events and All-Cause Mortality in Type 2 Diabetes: The ADVANCE Trial

Yoichiro Hirakawa, Hisatomi Arima, Sophia Zoungas, Toshiharu Ninomiya, Mark Cooper, Pavel Hamet, Giuseppe Mancia, Neil Poulter, Stephen Harrap, Mark Woodward, John Chalmers

Diabetes Care | AMER DIABETES ASSOC | Published : 2014

DOI: 10.2337/dc14-0199

University of Melbourne Researchers

Stephen Harrap Author Physiology

Grants

Funding Acknowledgements

The ADVANCE trial was funded by a grant from the National Health and Medical Research Council (NHMRC) of Australia. Y.H. holds a Research Fellowship Award from the Uehara Memorial Foundation for research activities. H. A. holds a Future Fellowship from the Australian Research Council. M. C. holds an Australia Fellowship from the NHMRC. M. W. holds a Senior Research Fellowship from the NHMRC.